6505--FY27 SIR-Spheres Y90 Resin Microspheres
248-NETWORK CONTRACT OFFICE 8 (36C248) · Department of Veterans Affairs C. W. Bill Young VA Medical Center 10000 Bay Pines Blvd, Bay Pines, Florida, 33744
Response status
Due in 10 days
Sep 14, 2026, 2:00 PM UTC
Responses remain open.
- Posted
- Aug 28, 2026
- Archive date
- Oct 14, 2026
- SAM status
- Active
Answer-first brief
What the source record says
- 248-NETWORK CONTRACT OFFICE 8 (36C248) published this presolicitation.
- The place of performance is Bay Pines, Florida.
- The notice uses NAICS 325412 (Pharmaceutical Preparation Manufacturing).
Procurement identity
- Notice ID
- bad0b4d432f84f84af713a104cb2db83
- Solicitation
- 36C24826Q0954
- Base type
- Presolicitation
- Version
- 1 of 1
Solicitation facts
Structured fields from the current SAM notice version. A dash means the source did not publish a value.
- Notice type
- Presolicitation
- Solicitation number
- 36C24826Q0954
- Set-aside
- —
- Set-aside code
- —
- Posted
- Aug 28, 2026
- Responses due
- Sep 14, 2026, 2:00 PM UTC
- Archive date
- Oct 14, 2026
- Archive type
- autocustom
- Base type
- Presolicitation
- Organization type
- OFFICE
- Benchmark category
- —
- Category confidence
- —
- Category source
- —
- Last seen
- Sep 5, 2026
Buyer and place
Office hierarchy and place of performance as published.
- Department
- VETERANS AFFAIRS, DEPARTMENT OF
- Department code
- —
- Subagency
- VETERANS AFFAIRS, DEPARTMENT OF
- Subagency code
- —
- Office
- 248-NETWORK CONTRACT OFFICE 8 (36C248)
- Organization path
- —
- Organization path codes
- —
- Office address
- TAMPA, FL, 33637, USA
- Place of performance
- Department of Veterans Affairs C. W. Bill Young VA Medical Center 10000 Bay Pines Blvd, Bay Pines, Florida, 33744
- City code
- —
- State
- Florida
- State code
- FL
- Postal code
- 33744
- Country
- —
Points of contact
Contact details from the current notice version.
primary
Cindy Smith
Notice description
Source text reproduced without an AI summary.
Comparable award range
Historical award values for work matched by the fixed rubric—not an estimate of this opportunity.
- Comparable awards
- 50
- Median
- $93,588
- Computed
- Sep 1, 2026
- Rubric
- comparables@2026.08.1
Comparable awards
The match score is decomposed so each comparison can be challenged.
| Award | Contractor | Value | Awarded | Score | Why it matched |
|---|---|---|---|---|---|
| CURASCRIPT: MEDICATION FOR INMATES | PRIORITY HEALTHCARE DISTRIBUTION INC | $62,140.11 | Jul 28, 2026 | 60 | Same product and service code (25), Same industry code (20), Same place of performance (8), Recent enough to be relevant (7) |
| CURASCRIPT: MEDICATION FOR INMATES | PRIORITY HEALTHCARE DISTRIBUTION INC | $24,792.22 | Jul 14, 2026 | 60 | Same product and service code (25), Same industry code (20), Same place of performance (8), Recent enough to be relevant (7) |
| NATIONAL DRUG CODE: 66215-0610-06 TRADE NAME: UPTRAVI 1000MCG TAB VA CLASS: CARDIOVASCULAR | PRIORITY HEALTHCARE DISTRIBUTION INC | $23,427.66 | May 11, 2026 | 60 | Same product and service code (25), Same industry code (20), Same place of performance (8), Recent enough to be relevant (7) |
| NATIONAL DRUG CODE: 66215-0602-06 TRADE NAME: UPTRAVI 1200MCG TAB VA CLASS: CARDIOVASCULA | PRIORITY HEALTHCARE DISTRIBUTION INC | $23,427.66 | May 18, 2026 | 60 | Same product and service code (25), Same industry code (20), Same place of performance (8), Recent enough to be relevant (7) |
| NATIONAL DRUG CODE: 66215-0610-06 TRADE NAME: UPTRAVI 1000MCG TAB VA CLASS: CARDIOVASCULAR | PRIORITY HEALTHCARE DISTRIBUTION INC | $23,427.66 | Jun 9, 2026 | 60 | Same product and service code (25), Same industry code (20), Same place of performance (8), Recent enough to be relevant (7) |
| NATIONAL DRUG CODE: 66215061006 TRADE NAME: UPTRAVI 1000MCG TAB VA CLASS: CARDIOVASCULAR A | PRIORITY HEALTHCARE DISTRIBUTION INC | $23,427.66 | Jul 15, 2026 | 60 | Same product and service code (25), Same industry code (20), Same place of performance (8), Recent enough to be relevant (7) |
| LENALIDOMIDE | EXELAN PHARMACEUTICALS INC | $5,337,255.70 | May 29, 2026 | 60 | Same product and service code (25), Same industry code (20), Same place of performance (8), Recent enough to be relevant (7) |
| EMERGENCY TYVASO 0.6MG/ML STARTER KIT (NDC 66302-0206-01) | PRIORITY HEALTHCARE DISTRIBUTION INC | $17,613.64 | May 7, 2026 | 60 | Same product and service code (25), Same industry code (20), Same place of performance (8), Recent enough to be relevant (7) |
| EMERGENCY TYVASO 0.6MG/ML REFILL KIT (NDC 66302-0206-02) | PRIORITY HEALTHCARE DISTRIBUTION INC | $15,746.12 | Jun 4, 2026 | 60 | Same product and service code (25), Same industry code (20), Same place of performance (8), Recent enough to be relevant (7) |
| TYVASO 0.6MG/ML REFILL KIT (NDC 66302-0206-02) FOR THE NORTHPORT VAMC. | PRIORITY HEALTHCARE DISTRIBUTION INC | $15,746.12 | Jul 2, 2026 | 60 | Same product and service code (25), Same industry code (20), Same place of performance (8), Recent enough to be relevant (7) |
| TYVASO 0.6MG/ML REFILL KIT (NDC 66302-0206-02) FOR THE NORTHPORT VAMC. | PRIORITY HEALTHCARE DISTRIBUTION INC | $15,746.12 | Jul 29, 2026 | 60 | Same product and service code (25), Same industry code (20), Same place of performance (8), Recent enough to be relevant (7) |
| JYNARQUE 45MG, 15 MG | OTSUKA AMERICA PHARMACEUTICAL INC | $20,378.21 | Jul 30, 2026 | 60 | Same product and service code (25), Same industry code (20), Same place of performance (8), Recent enough to be relevant (7) |
| LENALIDOMIDE | EXELAN PHARMACEUTICALS INC | $2,620,138.05 | Jun 3, 2026 | 60 | Same product and service code (25), Same industry code (20), Same place of performance (8), Recent enough to be relevant (7) |
| EO 14398 NUCLEAR MEDICINE RADIOPHARMACEUTICALS | RLS (USA) INC. | $165,401.00 | May 11, 2026 | 60 | Same product and service code (25), Same industry code (20), Same place of performance (8), Recent enough to be relevant (7) |
| GENERIC LENALIDOMIDE - P00001-DE-OBLIGATION OF EXCESS FUNDS. | EXELAN PHARMACEUTICALS INC | $2,500,000.00 | Jul 22, 2026 | 60 | Same product and service code (25), Same industry code (20), Same place of performance (8), Recent enough to be relevant (7) |
| LENALIDOMIDE/REVLIMID DOSE. P00002-DE-OBLIGATION OF EXCESS FUNDS. | EXELAN PHARMACEUTICALS INC | $1,500,000.00 | Jun 8, 2026 | 60 | Same product and service code (25), Same industry code (20), Same place of performance (8), Recent enough to be relevant (7) |
| LENALIDOMIDE - P00001 - IMPLEMENTATION OF EO 14398 | EXELAN PHARMACEUTICALS INC | $3,300,314.88 | May 28, 2026 | 60 | Same product and service code (25), Same industry code (20), Same place of performance (8), Recent enough to be relevant (7) |
| LENALIDOMIDE - P00001-IMPLEMENTATION OF EO 14398 | EXELAN PHARMACEUTICALS INC | $1,344,836.15 | May 28, 2026 | 60 | Same product and service code (25), Same industry code (20), Same place of performance (8), Recent enough to be relevant (7) |
| EO 14398 RADIOPHARMACEUTICALS NUCLEAR MEDICINE | RLS (USA) INC. | $303,486.05 | May 12, 2026 | 60 | Same product and service code (25), Same industry code (20), Same place of performance (8), Recent enough to be relevant (7) |
| GALLIUM GA68 DOTATATE (NETSPOT) INJECTION - DE-OBLIGATION OF EXCESS FUNDS | RLS (USA) INC. | $956,449.08 | Jun 3, 2026 | 60 | Same product and service code (25), Same industry code (20), Same place of performance (8), Recent enough to be relevant (7) |
Record provenance
Field-level lineage for the current opportunity version.
| Field | Source | Source as of | Parser | Transform |
|---|---|---|---|---|
| agency_name | SAM.gov Contract Opportunities | Aug 30, 2026 | sam_opportunity_snapshot@2026.08.3 | 2026.08.3 |
| archive_date | SAM.gov Contract Opportunities | Aug 30, 2026 | sam_opportunity_snapshot@2026.08.3 | 2026.08.3 |
| archive_type | SAM.gov Contract Opportunities | Aug 30, 2026 | sam_opportunity_snapshot@2026.08.3 | 2026.08.3 |
| base_type | SAM.gov Contract Opportunities | Aug 30, 2026 | sam_opportunity_snapshot@2026.08.3 | 2026.08.3 |
| city_name | SAM.gov Contract Opportunities | Aug 30, 2026 | sam_opportunity_snapshot@2026.08.3 | 2026.08.3 |
| contacts | SAM.gov Contract Opportunities | Aug 30, 2026 | sam_opportunity_snapshot@2026.08.3 | 2026.08.3 |
| country_code | SAM.gov Contract Opportunities | Aug 30, 2026 | sam_opportunity_snapshot@2026.08.3 | 2026.08.3 |
| description | SAM.gov Contract Opportunities | Aug 30, 2026 | sam_opportunity_snapshot@2026.08.3 | 2026.08.3 |
| naics_code | SAM.gov Contract Opportunities | Aug 30, 2026 | sam_opportunity_snapshot@2026.08.3 | 2026.08.3 |
| notice_id | SAM.gov Contract Opportunities | Aug 30, 2026 | sam_opportunity_snapshot@2026.08.3 | 2026.08.3 |
| notice_type | SAM.gov Contract Opportunities | Aug 30, 2026 | sam_opportunity_snapshot@2026.08.3 | 2026.08.3 |
| office_city | SAM.gov Contract Opportunities | Aug 30, 2026 | sam_opportunity_snapshot@2026.08.3 | 2026.08.3 |
| office_country_code | SAM.gov Contract Opportunities | Aug 30, 2026 | sam_opportunity_snapshot@2026.08.3 | 2026.08.3 |
| office_name | SAM.gov Contract Opportunities | Aug 30, 2026 | sam_opportunity_snapshot@2026.08.3 | 2026.08.3 |
| office_postal_code | SAM.gov Contract Opportunities | Aug 30, 2026 | sam_opportunity_snapshot@2026.08.3 | 2026.08.3 |
| office_state_code | SAM.gov Contract Opportunities | Aug 30, 2026 | sam_opportunity_snapshot@2026.08.3 | 2026.08.3 |
| organization_type | SAM.gov Contract Opportunities | Aug 30, 2026 | sam_opportunity_snapshot@2026.08.3 | 2026.08.3 |
| pop_postal_code | SAM.gov Contract Opportunities | Aug 30, 2026 | sam_opportunity_snapshot@2026.08.3 | 2026.08.3 |
| pop_street_address | SAM.gov Contract Opportunities | Aug 30, 2026 | sam_opportunity_snapshot@2026.08.3 | 2026.08.3 |
| posted_date | SAM.gov Contract Opportunities | Aug 30, 2026 | sam_opportunity_snapshot@2026.08.3 | 2026.08.3 |
| psc_code | SAM.gov Contract Opportunities | Aug 30, 2026 | sam_opportunity_snapshot@2026.08.3 | 2026.08.3 |
| response_deadline | SAM.gov Contract Opportunities | Aug 30, 2026 | sam_opportunity_snapshot@2026.08.3 | 2026.08.3 |
| sam_url | SAM.gov Contract Opportunities | Aug 30, 2026 | sam_opportunity_snapshot@2026.08.3 | 2026.08.3 |
| solicitation_number | SAM.gov Contract Opportunities | Aug 30, 2026 | sam_opportunity_snapshot@2026.08.3 | 2026.08.3 |
| state_code | SAM.gov Contract Opportunities | Aug 30, 2026 | sam_opportunity_snapshot@2026.08.3 | 2026.08.3 |
| subagency_name | SAM.gov Contract Opportunities | Aug 30, 2026 | sam_opportunity_snapshot@2026.08.3 | 2026.08.3 |
| title | SAM.gov Contract Opportunities | Aug 30, 2026 | sam_opportunity_snapshot@2026.08.3 | 2026.08.3 |
| upstream_active | SAM.gov Contract Opportunities | Aug 30, 2026 | sam_opportunity_snapshot@2026.08.3 | 2026.08.3 |
Sources and method
Figures on this page are computed from public federal award records. Numbers are never estimated or generated; where a figure is withheld, the reason is stated rather than filled in.
Comparable awards are scored on benchmark category, product and service code, industry code, buyer, place, recency, and contract type. Rubric version comparables@2026.08.1.
- 1Notice fields come from the SAM.gov contract opportunities record last seen Sep 5, 2026. SAM.gov remains authoritative.
- 2Computed from 50 completed federal awards using comparables@2026.08.1, as of Sep 1, 2026. Award values are neither unit prices nor a forecast.
Note 1 covers the solicitation record; note 2 covers the comparable range. No synthetic FAQ or inferred solicitation value is published.